---
title: "HSN Code for Oxyphen Butazone, Phenyl Butazone Formulations | HSN 30049064 GST Rate"
description: "Find HSN and GST Rates for 30049064 related to Oxyphen Butazone, Phenyl Butazone Formulations with BUSY Accounting - The reliable source for HSN and GST details in India."
canonical: "https://busy.in/hsn/hsn-30049064/"
---

# HSN Code 30049064: Oxyphen Butazone, Phenyl Butazone Formulations

- [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/)
- [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/)
- [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/)

## GST rates

| Description | CGST | SGST | IGST | CESS |
| --- | --- | --- | --- | --- |
| Other : Nonsteroidal antiinflammatory, analgesics and antipyratic drugs : Oxyphen butazone, phenyl butazone and formulations thereof | 6% | 6% | 12% | 0% |

## Frequently asked questions

### What products are classified under HSN 30049064 ?

It includes Oxyphen Butazone, Phenyl Butazone Formulations

### How much GST applies to Oxyphen Butazone, Phenyl Butazone Formulations?

Under HSN 30049064, Oxyphen Butazone, Phenyl Butazone Formulations attracts Varies when sold in taxable form. Describe the exact form on the invoice.

### Any common misclassification issue with Oxyphen Butazone, Phenyl Butazone Formulations?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

### Do e‑way bill and e‑invoice apply for Oxyphen Butazone, Phenyl Butazone Formulations?

e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies.

### Can we claim ITC on inputs used to trade Oxyphen Butazone, Phenyl Butazone Formulations?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

### How should mixed supplies be billed when Oxyphen Butazone, Phenyl Butazone Formulations is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Oxyphen Butazone, Phenyl Butazone Formulations; Nil for exempt items if applicable).

## India's trade performance: HSN Code 30049064 (FY 2024-25)

Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25).

- Exports: ₹8 Cr (+40.33% YoY) — 0.0002% of India's total exports
- Imports: Nil — 0.0000% of India's total imports
- Trade balance: ₹8 Cr (Surplus); surplus rank #3490 of 12657 HSN codes
- Share of Sub-Chapter 3004: 0.00% of its exports; import side 0.00%
- Rank within Sub-Chapter 3004: #122 of 149 by export value

### Key metrics

- Export CAGR: 9.18% (FY 2018-19 to FY 2024-25, 7 fiscal years)
- National export rank: #6112 of 12657 HSN codes by export value (FY 2024-25)
- Peak growth year: +86.84% in FY 2021-22
- Contribution to Sub-Ch. 3004: 0.00% of its exports (FY 2024-25)

## India export-import trade statistics: HSN Code 30049064

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

| FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY 2018-19 | 4.50 | 0.0002% | — | 0.00% | Nil | 0.0000% | — | 0.00% | +4.50 | #5993 |
| FY 2019-20 | 4.02 | 0.0002% | −10.67% | 0.00% | Nil | 0.0000% | — | 0.00% | +4.02 | #6116 |
| FY 2020-21 | 5.09 | 0.0002% | +26.62% | 0.00% | Nil | 0.0000% | — | 0.00% | +5.09 | #5915 |
| FY 2021-22 | 9.51 | 0.0003% | +86.84% | 0.01% | Nil | 0.0000% | — | 0.00% | +9.51 | #5550 |
| FY 2022-23 | 7.11 | 0.0002% | −25.24% | 0.01% | Nil | 0.0000% | — | 0.00% | +7.11 | #6062 |
| FY 2023-24 | 5.43 | 0.0002% | −23.63% | 0.00% | Nil | 0.0000% | — | 0.00% | +5.43 | #6486 |
| FY 2024-25 | 7.62 | 0.0002% | +40.33% | 0.00% | Nil | 0.0000% | — | 0.00% | +7.62 | #6112 |

- CAGR (7-year): exports 9.18%/yr, imports —/yr (consistently Surplus)

## Key trade insights: HSN Code 30049064 export-import analysis

### Consistent export growth: 9.18% CAGR over 7 years

India's exports under HSN Code 30049064 have grown at a compound annual rate of 9.18% over 7 fiscal years, rising from ₹4.50 Crore in FY 2018-19 to ₹7.62 Crore in FY 2024-25.

### HSN Code 30049064 ranked #6112 among all 12657 HSN codes by export value

In FY 2024-25, HSN Code 30049064 ranks #6112 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #122 of 149. By trade surplus, it ranks #3490 of 12657.

### FY 2021-22 was the strongest growth year for HSN Code 30049064 exports

The strongest single-year export movement for HSN Code 30049064 was recorded in FY 2021-22, when exports surged by 86.84% over the prior year.

### India maintains a trade surplus of ₹7.62 Crore in HSN Code 30049064 goods

In FY 2024-25, India's exports of ₹7.62 Cr exceeded imports of ₹0.00 Cr, resulting in a trade surplus of ₹7.62 Crore — ranking #3490 of 12657 by surplus magnitude.

### HSN Code 30049064 contributes 0.00% of Sub-Chapter 3004 exports — ranked #122

Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049064 ranks #122 by export value — accounting for 0.00% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.00% share.

## Related HSN Codes in Sub-Chapter 3004

Ranked by export value (FY 2024-25).

| Rank | HSN Code | Exports (FY 2024-25) |
| --- | --- | --- |
| #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr |
| #2 | [HSN Code 30049049: Other \| Anticancer Drugs](https://busy.in/hsn/hsn-30049049/) | ₹19,872 Cr |
| #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr |
| #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr |
| #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr |
| #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr |
| #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr |
| #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr |
| #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr |
| #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr |
| #122 | HSN Code 30049064: Oxyphen Butazone, Phenyl Butazone Formulations (this hsn code) | ₹8 Cr |